It is a pharma private limited company based in Ranchi, Jharkhand, India, established in 2016.
2016 | Ranchi, Jharkhand, India | ActiveMedon Pharmaceuticals Private Limited, a active private limited company, was established on 26 August 2016 in Ranchi, Jharkhand, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999JH2016PTC009109. Registered under ROC Roc Ranchi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as Medon Pharmaceuticlas Private Limited. It upholds a compliant status. Its leadership includes Kaushlendra Kumar (Director), Kamlawati Devi (Director), Ravi Kumar (Director). It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 235, Bhola Chaubey Gali, Chutia, Ranchi, Jharkhand, 834001.
U74999JH2016PTC009109
009109
26 August 2016
₹1.00 M
₹1.00 M
Roc Ranchi
Unlisted
Active
Explore comprehensive insights into Medon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kaushlendra Kumar | Director | 26 Aug 2016 | Current |
| Kamlawati Devi | Director | 26 Aug 2016 | Current |
| Ravi Kumar | Director | 10 Jun 2020 | Current |
| Ankur Awathi | Director | 10 Jun 2020 | Current |
| Priyanka Kumari | Director | 10 Jun 2020 | Current |
| Manju Awasthi | Director | 10 Jun 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 21.63% decrease. The company also saw a substantial fall in profitability, with a 59.47% decrease in profit. The company's net worth moved up by a moderate rise of 1.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Medon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 May 2017 | Others | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Medon Pharmaceuticals has a workforce of 0 employees as of Mar 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Medon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Medon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ranchi. was documented.
Progress on Riches Kumar was appointed as a Director was appointed as a Director on 17 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
Ravi Kumar was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 5 years 5 months . was recorded as a recent event.
Progress on Ankur Awathi was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 5 years 5 months . was documented.
Progress on Priyanka Kumari was appointed as a Director was appointed as a Director on 10 Jun 2020 & has been associated with this company since 5 years 5 months . was documented.
The CIN of Medon Pharmaceuticals Private Limited is U74999JH2016PTC009109.
Medon Pharmaceuticals Private Limited is headquartered at H.No. 235, Bhola Chaubey Gali, Chutia, Ranchi, Jharkhand, 834001.
Medon Pharmaceuticals Private Limited was incorporated on 26 August 2016.
The current directors of Medon Pharmaceuticals Private Limited are
The primary industry of Medon Pharmaceuticals Private Limited is Trade.
Medon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medon Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Medon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX